Skip to main content

Leica Acquires DNA Fish Probes and Microarray Labeling Firm Kreatech

NEW YORK (GenomeWeb News) – Leica Biosystems today announced it has acquired Kreatech Diagnostics for an undisclosed amount.

Kreatech, based in Amsterdam, is a provider of DNA fluorescent in situ hybridization probes and target labeling reagents for microarrays. It will join Leica's Advanced Staining Business Unit based in Newcastle-upon-Tyne UK.

In a statement, Matthias Weber, president of Leica, a Danaher company, said the deal allows Leica to better serve its cytogenetics and anatomic pathology customers and will "enable us to actively support the future development of personalized medicine by research and drug development companies."

Leica offers its ThermoBrite and Bond systems for labeling tissue specimens for diagnostic interpretation in cytogenetics and pathology laboratories.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.